Eureka Forbes logo

Eureka Forbes CEO, MD, chairman, board of directors and AGM

NSE: EUREKAFORBBSE: 543482Consumer DurablesSmall Cap

Last close ₹309.70down ₹7.10 (2.24%)BSE ₹310.10

Share price at the NSE close on 23 Oct 2026. Previous close ₹316.80.

52-week range of traded prices to 23 Oct 2026
₹299.80Low, 23 Oct 2026₹668.30High, 28 Nov 2025
Market cap
₹5,997 Cr574th largest listed
P/E
33.1
P/E without one-offs
29.7
P/B
1.3
Dividend yield
Nonein the last 12 months
ROE
4.0%
ROE without one-offs
4.5%
ROCE
5.4%
Debt to equity
0.00
Volume, NSE
2,48,92051.3% delivered

Eureka Forbes board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonArvind Uppal
  • Managing director and CEOPratik Rashmikant Pota
  • Company Secretary and Compliance OfficerShilpa Jain

7 directors4 independent1 executive2 non-executive

  • Arvind Uppal · ChairpersonNon-executive · joined Apr 2022 · 4 listed boards · 2 as independent · 6 committee seats, 4 as chair
  • Homi Adi KatgaraIndependent · joined Jan 2022 · reappointed Jan 2022 · 53 months as independent · 1 listed board · 1 as independent
  • Vinod RaoIndependent · joined Apr 2022 · reappointed Apr 2022 · 50 months as independent · 3 listed boards · 3 as independent · 4 committee seats, 2 as chair
  • Sahil Dilip DalalNon-executive · joined Apr 2022 · 1 listed board · 3 committee seats
  • Gurveen SinghIndependent · joined Apr 2022 · reappointed Apr 2022 · 50 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Pratik Rashmikant Pota · Managing director and CEOExecutive · joined Aug 2022 · 1 listed board · 1 committee seat
  • Shashank Shankar SamantIndependent · joined Oct 2022 · reappointed Oct 2022 · 44 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 19 May 20267 of 7 present4 independent · 62 days in between
    • 17 Mar 20266 of 7 present3 independent · 40 days in between
    • 4 Feb 20267 of 7 present4 independent
  • Audit Committee

    Chair Vinod Rao

    Gurveen Singh, Sahil Dilip Dalal

    • 19 May 20263 of 3 present2 independent · 5 days in between
    • 13 May 20262 of 3 present2 independent · 97 days in between
    • 4 Feb 20263 of 3 present2 independent · no day in between
    • 3 Feb 20263 of 3 present2 independent
  • Nomination and remuneration committee

    Chair Gurveen Singh

    Vinod Rao, Homi Adi Katgara, Sahil Dilip Dalal

    • 19 May 20264 of 4 present3 independent · 59 days in between
  • Stakeholders Relationship Committee

    Chair Arvind Uppal

    Pratik Rashmikant Pota, Vinod Rao, Gurveen Singh, Shashank Shankar Samant

    • 4 Feb 20265 of 5 present3 independent
  • Risk Management Committee

    Chair Vinod Rao

    Arvind Uppal, Sahil Dilip Dalal, Gurveen Singh, Shashank Shankar Samant

    • 20 Mar 20264 of 5 present2 independent · 43 days in between
  • Corporate Social Responsibility Committee

    Chair Gurveen Singh

    Pratik Rashmikant Pota, Homi Adi Katgara, Vinod Rao

    • 19 May 20264 of 4 present3 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • M/s. Deloitte Haskins & Sells LLPPeer-review certificate valid to Jul 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Eureka Forbes AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Eureka Forbes share news and announcements

Annual general meeting, 19 Aug 2026

36,522 shareholders on the register on 12 Aug 2026; present: 1 promoter and 53 others; votes counted by Mihen Halani / M/s. Mihen Halani & Associates, Practicing Company Secretaries.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2026 together with the Report of the Board of Directors and the Auditors' thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.35%

    Turnout: all 77.47% · promoters 100.00% · institutions 72.64% · other public 0.12%

  2. To appoint a Director in place of Mr. Sahil Dalal (DIN:07350808) who retires by rotation and being eligible, offers his candidature for re-appointment.
    Ordinary
    95.37% for4.63% against

    Against: promoters 0.00% · institutions 24.03% · other public 8.88%

    Turnout: all 77.48% · promoters 100.00% · institutions 72.70% · other public 0.12%

  3. To ratify remuneration payable to Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 8.63%

    Turnout: all 77.48% · promoters 100.00% · institutions 72.70% · other public 0.12%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 19 Sep 2025, 4 resolutions

31,848 shareholders on the register on 12 Sep 2025; present: 1 promoter and 49 others; votes counted by M/s. Mihen Halani & Associates, Practicing Company Secretaries / Mihen Halani.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2025 together with the Report of the Board of Directors and the Auditors' thereon.MoreLess
    Ordinary
    99.13% for0.87% against

    Against: promoters 0.00% · institutions 2.78% · other public 0.15%

    Turnout: all 48.89% · promoters 53.66% · institutions 72.65% · other public 0.31%

  2. To appoint a Director in place of Mr. Arvind Uppal (DIN:00104992) who retires by rotation and being eligible, offers his candidature for re-appointment.
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 0.91% · other public 1.60%

    Turnout: all 48.89% · promoters 53.66% · institutions 72.67% · other public 0.31%

  3. To ratify remuneration payable to Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.56%

    Turnout: all 48.89% · promoters 53.66% · institutions 72.67% · other public 0.31%

  4. Appointment of Secretarial Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.57%

    Turnout: all 48.89% · promoters 53.66% · institutions 72.67% · other public 0.31%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 20 Sep 2024, 3 resolutions

Present: 1 promoter and 73 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2024 together with the Report of the Board of Directors and the Auditors’ thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 71.25% · promoters 100.00% · institutions 37.81% · other public 6.21%

  2. To appoint a Director in place of Mr. Sahil Dalal (DIN:07350808) who retires by rotation and being eligible, offers his candidature for re-appointment.
    Ordinary
    99.61% for0.39% against

    Against: promoters 0.00% · institutions 3.69% · other public 0.00%

    Turnout: all 70.84% · promoters 100.00% · institutions 36.54% · other public 6.21%

  3. To ratify remuneration payable to Cost Auditors
    Ordinary
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.55%

    Turnout: all 71.17% · promoters 100.00% · institutions 37.39% · other public 6.21%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 19 Aug 2026, 7 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2026 together with the Report of the Board of Directors and the Auditors' thereon.MoreLess
    7 for0 against
  • To appoint a Director in place of Mr. Sahil Dalal (DIN:07350808) who retires by rotation and being eligible, offers his candidature for re-appointment.
    7 for0 against
  • To ratify remuneration payable to Cost Auditors
    7 for0 against

Mutual fund votes, meeting of 19 Sep 2025, 12 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2025 together with the Report of the Board of Directors and the Auditors' thereon.MoreLess
    12 for0 against
  • To appoint a Director in place of Mr. Arvind Uppal (DIN:00104992) who retires by rotation and being eligible, offers his candidature for re-appointment.
    12 for0 against
  • To ratify remuneration payable to Cost Auditors
    12 for0 against
  • Appointment of Secretarial Auditors
    12 for0 against
5 earlier meetings

Mutual fund votes, meeting of 20 Sep 2024, 9 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2024 together with the Report of the Board of Directors and the Auditors’ thereon.MoreLess
    9 for0 against
  • To appoint a Director in place of Mr. Sahil Dalal (DIN:07350808) who retires by rotation and being eligible, offers his candidature for re-appointment.
    9 for0 against
  • To ratify remuneration payable to Cost Auditors
    9 for0 against

Mutual fund votes, meeting of 22 Sep 2023, 7 fund houses

  • Accept Financial Statements and Statutory Reports
    1 for0 against
  • Adoption of standalone and consolidated financial statements for the year ended 31 March 2023
    1 for0 against
  • Approve overall managerial remuneration in excess of 11% of net profits for FY23 (Rs. 47.7 mn in excess of regulatory thresholds)
    1 for0 against
  • Approve Overall Managerial Remuneration to All Directors Including the Managing Director, CEO (Current and Former), and Non-Executive Directors
    Against HSBC Mutual Fund
    • HSBC Mutual FundNon-executive directors participate in performance-based incentive schemes.
    0 for1 against
  • Approve payment of commission of Rs. 2.7 mn (per director) to Non-Executive Directors from FY23 onwards and approve payment of commission aggregating Rs. 12.2 mn for FY23, of which Rs. 7.3 mn was in excess of regulatory thresholds (1% of net profits)MoreLess
    1 for0 against
  • Approve Payment of Commission to Non-Executive Directors
    Against HSBC Mutual Fund
    • HSBC Mutual FundA vote AGAINST this resolution is warranted as the approval will be valid till perpetuity and shareholders will not get to review the payments in the future
    0 for1 against
  • Approve Remuneration of Cost Auditors
    1 for0 against
  • Approve waiver of excess managerial remuneration of Rs 5,563,080 for FY23 to former Managing Director and CEO: Marzin R. Shroff (DIN: 00642613)
    1 for0 against
  • Approve waiver of excess managerial remuneration of Rs 59,221,051 to Pratik Pota (DIN: 00751178) as Managing Director and CEO for FY23
    1 for0 against
  • Approve Waiver of the Excess Managerial Remuneration of Marzin R. Shroff as Former Managing Director and CEO
    1 for0 against
  • Approve Waiver of the Excess Managerial Remuneration of Pratik Rashmikant Pota as Managing Director and CEO
    1 for0 against
  • Ratification of remuneration of Rs.7,00,000 plus applicable taxes and out of pocket expenses payable to M/s. J. Chandra & Associates, Cost Accountants, the Cost Auditors appointed by the Board of Directors of the Company, to conduct the audit of the cost accounts of the Company for the Financial Year ending March 31, 2024.MoreLess
    5 for0 against
  • Ratify remuneration of Rs. 700,000 to J Chandra & Associates as cost auditors for FY24
    1 for0 against
  • Reappoint Arvind Uppal (DIN: 00104992) as Non-Executive Non-Independent Director, liable to retire by rotation
    1 for0 against
  • Reelect Arvind Uppal as Director
    1 for0 against
  • To appoint a Director in place of Mr. Arvind Uppal (DIN: 00104992) who retires by rotation and being eligible, offers his candidature for re-appointment.
    5 for0 against
  • To pay Annual Commission of Rs.27,00,000 per Director to Non-Executive Directors of the Company with effect from the Financial Year 2022-23.
    Against Axis Mutual Fund
    • Axis Mutual FundThe company proposes commission of Rs. 2.7 mn per annum for each non-executive director, FY23 onwards. The value of commission for FY23 comes to Rs. 12.2 mn, of which Rs. 7.3 mn is in excess of regulatory thresholds. The proposed commission of Rs. 2.7 mn per director is in line with the market practice. However, the company has not defined a tenure for the commission payment and thus the resolution is effectively valid for perpetuity. We believe shareholders must get a change to periodically approve such payments and thus, we are unable to support the resolution.
    4 for1 against
  • To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2023 together with the Report of the Board of Directors and the Auditors' thereon and b. the Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2023 together with the Report of the Auditors' thereon.MoreLess
    Against PGIM India Mutual Fund
    • PGIM India Mutual FundUnqualified Financial Statements. Governance Concern: Undisputed Statutory Dues unpaid for more than 2 years.
    4 for1 against
  • Waiver of recovery of the excess remuneration amounting to INR 5,92,21,051 payable to Mr. Pratik Rashmikant Pota (DIN: 00751178), Managing Director & CEO for the Financial Year 2022-23.
    5 for0 against
  • Waiver of recovery of the excess remuneration amounting to INR 55,63,080 payable to Mr. Marzin R. Shroff (DIN: 00642613), former Managing Director & CEO for the Financial Year 2022-23.
    5 for0 against
  • Waiver of recovery of the excess remuneration payable to all the Directors in the form of fixed pay, commission or otherwise including the Managing Director & CEO (current and former) and the Non-Executive Directors for the Financial Year 2022- 23 exceeding the overall managerial remuneration by Rs.4,76,70,873 calculated based on the maximum managerial remuneration limit of 11% of net profits calculated under Section 198 of the Companies Act, 2013.MoreLess
    5 for0 against

Mutual fund votes, meeting of 19 Apr 2023, 4 fund houses

  • Approval of proposed grant of Stock Options equal to or exceeding 1% (One Percent) of issued capital of the Company under Eureka Forbes - Employee Stock Option Plan 2022 at the time of grant to identified employee(s).MoreLess
    Against Axis Mutual Fund, HDFC Mutual Fund
    • Axis Mutual FundPratik Pota was appointed as MD/ CEO in August 2022 after Advent International’s acquisition of Eureka Forbes Limited. He previously served as CEO of Jubilant Foodworks Limited. Approval for his appointment as MD/ CEO of Eureka Forbes was sought through the November 2022 postal ballot. The company now seeks shareholder approval for grant of ESOPs to him under ESOP 2022, equal to/ in excess of 1% of issued capital in any financial year. Based on the shareholding structure on 31 December 2022, at 1% of issued capital – he is eligible to receive stock options equal to/ in excess of 1.93 mn per financial year. Even if he is granted just 1.93 mn stock options, basis the current market price, the value of ESOP compensation alone aggregates Rs. 572.5 mn, which is high for the size and complexity of the business. The company has neither capped the quantum of stock options that may be granted, nor disclosed the vesting criteria – we do not support such enabling resolutions that deprive shareholders of taking informed decisions.
    • HDFC Mutual FundThe value of ESOP compensation to the MD is high considering the size and complexity of the business
    0 for2 against
  • Approve Grant of Employee Stock Options Under Eureka Forbes - Employee Stock Option Plan 2022 to Identified Employee(s)
    Against HSBC Mutual Fund
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because:- The scheme offers flexibility to grant stock options at an exercise price at a discount to the market price on the grant date.- The exact performance conditions and targets for vesting have not been disclosed.- The company has failed to provide a compelling justification for the grant of Employee Stock Options equal to or exceeding one percent of the issued capital of the company, under the plan to the MD and CEO of the company.
    0 for1 against
  • To authorize Board of Directors to offer, create and grant from time to time such number of Stock Options (“Options”) in one or more tranches under ESOP 2022 exercisable into equal number of Equity Shares of face value of Rs. 10/- each fully paid up, as per the terms of ESOP 2022, during any one financial year, which may be equal to or exceed 1% (one percent) of the issued capital of the Company, at the time of grant of options to Mr. Pratik Rashmikant Pota Managing Director & CEO of the CompanyMoreLess
    1 for0 against

Mutual fund votes, meeting of 22 Dec 2022, 2 fund houses

  • Appointment of M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, having Firm Registration No.: 117366W/W-100018, as Statutory Auditors of the Company who shall hold office for a term of 05 (Five) consecutive years commencing from the conclusion of 13th Annual General Meeting till the conclusion of 18th Annual General Meeting to be held in a calendar year 2027 at such remuneration.MoreLess
    1 for0 against
  • Appointment of Mr. Shashank Shankar Samant (DIN: 09733485) as a Non-Executive Independent Director for a term of 05 (Five) consecutive years effective from October 10, 2022 till October 09, 2027 and shall not be liable to retire by rotation.MoreLess
    1 for0 against
  • Consider and approve payment of Managerial Remuneration and waiver of excess Managerial Remuneration payable to Managing Director and Chief Executive Officer Managing Director and CEO.
    1 for0 against
  • Consider and approve payment of Managerial Remuneration and waiver of excess Managerial Remuneration payable to Managing Director & Chief Executive Officer (Managing Director & CEO).
    1 for0 against
  • Payment of a sum not exceeding Rs 56.00 Lakhs including Rs 48.01 Lakhs being more than 1% of the Net Profit to Non-Executive Directors of the company.
    1 for0 against
  • Ratification of remuneration of Rs 7.00 Lakhs plus applicable taxes and out of pocket expenses payable to M/s. J Chandra & Associates, Cost Accountants, the Cost Auditors appointed by the Board of Directors of the Company, to conduct the audit of the cost accounts of the Company for the Financial Year ending March 31, 2023.MoreLess
    1 for0 against
  • To appoint Mr. Sahil Dilip Dalal (DIN: 07350808) as a Director liable to retire by rotation and being eligible seeks re-appointment.
    1 for0 against
  • To appoint Mr. Sahil Dilip Dalal DIN 07350808 as a Director liable to retire by rotation and being eligible seeks reappointment
    1 for0 against
  • To appoint Mr. Shashank Shankar Samant DIN 09733485 as NonExecutive and Independent Director.
    1 for0 against
  • To appoint Ms. Deloitte Haskins and Sells LLP Chartered Accountants having Firm Registration No. 117366WW100018 as Statutory Auditors of the Company.
    1 for0 against
  • To pay Commission to NonExecutive Directors.
    Against HSBC Mutual Fund
    • HSBC Mutual FundA vote AGAINST is warranted as NEDs participate in performance-based schemes.
    0 for1 against
  • To ratify the remuneration payable to Ms. J Chandra and Associates Cost Accountants Cost Auditors to conduct the audit of the cost accounts of the Company for the Financial Year ending March 31 2023.
    1 for0 against
  • To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2022 together with the Report of the Board of Directors and the Auditors thereon; and b. the Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2022 together with the Report of the Auditors thereon.MoreLess
    1 for0 against
  • To receive consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31 2022 together with the Report of the Board of Directors and the Auditors thereonMoreLess
    1 for0 against

Mutual fund votes, meeting of 10 Nov 2022, 1 fund house

  • Appointment of Mr. Pratik Rashmikant Pota (DIN: 00751178) as a Director of the Company.
    1 for0 against
  • Appointment of Mr. Pratik Rashmikant Pota (DIN: 00751178) as Managing Director and Chief Executive Officer of the Company and including remuneration.
    1 for0 against
  • Consider and approve ‘Eureka Forbes - Employee Stock Option Plan 2022’ (ESOP 2022/ Plan).
    Against Axis Mutual Fund
    • Axis Mutual FundThe company’s ESOP 2022 Plan is for issuance of upto a maximum 17.5 mn options, which will result in a dilution of ~8% on the expanded capital base. The exercise price of the stock options will be decided by the committee and could be at Rs. 210.0 per share or at the market price. At an exercise price of Rs. 210.0, there is a likelihood that granted options could be at discount higher than 20%. At the current market price of Rs. 511.7 as on 20 October 2022, the discount is 41%. We do not favour ESOP schemes where the options are granted at a significant discount to market price o where there is no clarity on the performance parameters for vesting, if any. We believe ESOPs are ‘pay at risk’ options that employees accept at the time of grant. Further, with a deep discount to market price, there is no alignment between the interests of investors and those of employees and also with stock options being in the-money ab initio, these have limited use as incentive structures
    0 for1 against
  • Grant of employee stock options to the employees of Subsidiary Company(ies) of the Company under ‘Eureka Forbes - Employee Stock Option Plan 2022’
    Against Axis Mutual Fund
    • Axis Mutual FundWe do not favour ESOP schemes where the options are granted at a significant discount to market price o where there is no clarity on the performance parameters for vesting, if any. We believe ESOPs are ‘pay at risk’ options that employees accept at the time of grant. Further, with a deep discount to market price, there is no alignment between the interests of investors and those of employees and also with stock options being in the-money ab initio, these have limited use as incentive structures
    0 for1 against
  • Grant of employee stock options to the employees of the Group Company (ies) including Associate Company (if any) of the Company under ‘Eureka Forbes- Employee Stock Option Plan 2022’
    Against Axis Mutual Fund
    • Axis Mutual FundWe do not favour ESOP schemes where the options are granted at a significant discount to market price o where there is no clarity on the performance parameters for vesting, if any. We believe ESOPs are ‘pay at risk’ options that employees accept at the time of grant. Further, with a deep discount to market price, there is no alignment between the interests of investors and those of employees and also with stock options being in the-money ab initio, these have limited use as incentive structures
    0 for1 against
  • To increase the Authorized Share Capital of the Company from Rs. 200,00,00,000/- divided into 20,00,00,000 Equity Shares of Rs. 10/- to Rs. 250,00,00,000/- divided into 25,00,00,000 Equity Shares of Rs. 10/- each by the creation of additional 5,00,00,000 equity shares of Rs. 10/- each ranking pari-passu in all respect with the existing equity shares of the Company as per the Memorandum and Articles of Association of the Company.MoreLess
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines

Reported in the filing for the quarter to Jun 2026.

  • Fine or penaltyEmployees' Provident Fund Organisation (EPFO Kolkata)Since 1 Apr 2026

    The Company had multiple instances of non-seeding of Universal Account Numbers (UANs) with Aadhaar, resulting in non-compliance with the applicable Aadhaar seeding requirements. Consequently, challans pertaining to these instances were generated and paid from April 2026 to May 2026, including the applicable amounts under Section 7Q and Section 14B of the Employees' Provident Funds and Miscellaneous Provisions Act, 1952.

    The Company had multiple instances of non-seeding of Universal Account Numbers (UANs) with Aadhaar, resulting in non-compliance with the applicable Aadhaar seeding requirements. Due to which multiple challans from EPFO for the above matter were generated from April 2026 to May 2026. Consequently, challans pertaining to these instances were generated and paid between the same period, including the applicable amounts under Section 7Q and Section 14B of the Employees' Provident Funds and Miscellaneous Provisions Act, 1952. Note: We have added the date of receipt of challan as April 01, 2026. However, the same is spanned into multiple dates in April 2026 and May 2026.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.